According to Future Market Insights (FMI), the global direct oral anticoagulants (DOACs) market is expected to witness robust growth, driven by the increasing prevalence of cardiovascular diseases, rising incidence of atrial fibrillation, growing awareness of stroke prevention, and continuous advancements in anticoagulation therapies. The adoption of novel oral anticoagulants offering improved...
SPARK Website
English